Serum markers for recurrence in patients with differentiated thyroid cancer after combined treatment and the retreatment results

Serum markers for recurrence in patients with differentiated thyroid cancer after combined treatment and the retreatment results

Purpose: to analyze in a comparative perspective certain factors influencing recurrent differentiated thyroid cancer (DTC) in patients with an increasing concentration of serum thyroglobulin (Tg) and serum antithyroglobulin antibodies (TgA) in the blood serum. Patients and methods. The outcomes of...

Full description

Bibliographic Details
Main Authors:	Dmitriy Kirillovich Fomin, Elena Igorevna Vasilenko, Mariya Alekseevna Karalkina
Format:	Article
Language:	Russian
Published:	Endocrinology Research Centre 2015-02-01
Series:	Клиническая и экспериментальная тиреоидология
Subjects:	differentiated thyroid carcinoma radioiodine therapy marker of recurrent dtc thyroglobulin antithyro-globulin antibodies
Online Access:	https://cet-endojournals.ru/ket/article/viewFile/6892/4964

Similar Items

Restaging of differentiated thyroid carcinoma with SPECT/CT after radioiodine therapy
by: Mariya Alekseevna Karalkina, et al.
Published: (2015-07-01)

Postoperative Stimulated Thyroglobulin Level and Recurrence Risk Stratification in Differentiated Thyroid Cancer
by: Xue Yang, et al.
Published: (2015-01-01)

Is 131I ablation necessary for patients with low-risk papillary thyroid carcinoma and slightly elevated stimulated thyroglobulin after thyroidectomy?
by: Pedro Weslley Rosario, et al.

Low versus high radioiodine activity for ablation of the thyroid remnant after thyroidectomy in Han Chinese with low-risk differentiated thyroid cancer
by: Lv RB, et al.
Published: (2017-08-01)

Lung Metastases From Papillary Thyroid Cancer With Persistently Negative Thyroglobulin and Elevated Thyroglobulin Antibody Levels During Radioactive Iodine Treatment and Follow-Up: Long-Term Outcomes and Prognostic Indicators
by: Zhong-Ling Qiu, et al.
Published: (2020-01-01)

Utility of Stimulated Thyroglobulin in Reclassifying Low Risk Thyroid Cancer Patients’ Following Thyroidectomy and Radioactive Iodine Ablation: A 7-Year Prospective Trial
by: Anwar A. Jammah, et al.
Published: (2021-02-01)

Clinical predictors of I-131 therapy failure in differentiated thyroid cancer by machine learning: A single-center experience
by: David J Lubin, et al.
Published: (2021-01-01)

A Multiplex Thyroid-Specific Assay for Quantification of Circulating Thyroid Cell-Free RNA in Plasma of Thyroid Cancer Patients
by: Samantha Peiling Yang, et al.
Published: (2021-08-01)

ANTI-THYROGLOBULIN ANTIBODIES IN PATIENTS WITH AUTOIMMUNE THYROIDITIS DURING L-THYROXINE TREATMENT
by: O. A. Shashkova, et al.
Published: (2014-07-01)

ANTI-THYROGLOBULIN ANTIBODIES IN PATIENTS WITH AUTOIMMUNE THYROIDITIS DURING L-THYROXINE TREATMENT
by: O. A. Shashkova, et al.
Published: (2014-07-01)

Distinguishing Patients With Distant Metastatic Differentiated Thyroid Cancer Who Biochemically Benefit From Next Radioiodine Treatment
by: Ri Sa, et al.
Published: (2020-11-01)

Successful pregnancy without disease progression of radioiodine refractory papillary thyroid carcinoma: a case report
by: Yuchen Jin, et al.
Published: (2017-11-01)

Evaluation of thyroid dysfunction and thyroid autoantibodies in patients with Vitiligo
by: Mohammadi R, et al.
Published: (2016-06-01)

Serum tumor markers in thyroid diseases
by: R.D. Makar, et al.
Published: (2019-03-01)

Recombinant human thyrotropin in radioiodine diagnostics and radioiodine ablation of patients with well-differentiated thyroid cancer: the first experience in Russia
by: Ivan I. Dedov, et al.
Published: (2018-12-01)

Clinical outcome of patients with differentiated thyroid cancer and raised antithyroglobulin antibody levels: a retrospective study
by: Manish Ora, et al.
Published: (2021-04-01)

Clinical analysis of thyroglobulin antibody and thyroid peroxidase antibody and their association with vitiligo
by: Yifen Yang, et al.
Published: (2014-01-01)

Clinical significance of thyroglobulin autoantibodies enhancement in patients with differentiated thyroid cancer after thyroidectomy and radioiodine therapy
Published: (2013-09-01)

CYTOLOGICAL CHARACTERISTICS OF POSTOPERATIVE METASTASES OF PAPILLARY THYROID CANCER DURING THE DEVELOPMENT OF SECONDARY RADIOIODINE REFRACTORINESS
by: Anna Zelinskaya, et al.
Published: (2020-01-01)

Correlation and presentation of thyroid functional status with thyroid autoantibodies in long-term follow-up of autoimmune thyroiditis: A study of 116 cases
by: Kuei-Mei Chou, et al.
Published: (2015-11-01)

Impact of 18F-FDG PET/CT on Clinical Management of Suspected Radio-Iodine Refractory Differentiated Thyroid Cancer (RAI-R-DTC)
by: Elisa Lodi Rizzini, et al.
Published: (2021-08-01)

Dietary Factors Associated with Plasma Thyroid Peroxidase and Thyroglobulin Antibodies
by: Antonela Matana, et al.
Published: (2017-10-01)

Predictive Value of Thyroglobulin Changes for the Curative Effect of Radioiodine Therapy in Patients With Metastatic Differentiated Thyroid Carcinoma
by: Congcong Wang, et al.
Published: (2021-05-01)

Thyroid function and thyroid autoantibodies in patients with chronic spontaneous urticaria
by: Magdalena Czarnecka-Operacz, et al.
Published: (2017-12-01)

Predictors of thyroglobulin in the lymph nodes recurrence of papillary thyroid carcinoma undergoing total thyroidectomy
by: Zhichao Xing, et al.
Published: (2021-01-01)

In properly selected patients with differentiated thyroid cancer, antithyroglobulin antibodies decline after thyroidectomy and their sole presence should not be an indication for radioiodine ablation
by: Luis Felipe Zavala, et al.
Published: (2019-04-01)

Effects of energy-based ablation on thyroid function in treating benign thyroid nodules: a systematic review and meta-analysis
by: Yuan Fei, et al.
Published: (2020-01-01)

Prognosis of papillary thyroid cancers with positive serum thyroglobulin antibody after total thyroidectomy
by: Sheng-Fong Kuo, et al.
Published: (2017-05-01)

Pre-Ablation Thyroglobulin Levels and Persistence / Recurrence Associated to Early Differentiated Thyroid Cancer
by: Arturo Mejía López, et al.
Published: (2014-01-01)

Treatment-related adverse effects with TKIs in patients with advanced or radioiodine refractory differentiated thyroid carcinoma: a systematic review and meta-analysis
by: Yu S, et al.
Published: (2019-02-01)

Combined treatment of the highly differentiated cancer of thyroid gland: recombinant human thyrotropin-alpha is in the focus
by: Петро Петрович Зінич
Published: (2016-03-01)

CRITERIA OF WELL-DIFFERENTIATED THYROID CARCINOMA RESISTANCE TO RADIOIODINE THERAPY
by: P. O. Rumyantsev, et al.
Published: (2015-04-01)

Sarcoidosis and Thyroid Autoimmunity
by: Piera Fazzi, et al.
Published: (2017-08-01)

Clinical laboratory verification of thyroglobulin concentrations in the presence of autoantibodies to thyroglobulin: comparison of EIA, radioimmunoassay and LC MS/MS measurements in an Urban Hospital
by: Sarah E. Wheeler, et al.
Published: (2017-12-01)

Endocrinological Evaluations of a Neurofibromatosis Type 1 Cohort: Is it Necessary to Evaluate Autoimmune Thyroiditis in Neurofibromatosis Type 1?
by: Serhat Güler, et al.
Published: (2017-12-01)

Anti-Thyroid Peroxidase and Anti-Thyroglobulin Autoantibodies in the Cerebrospinal Fluid of Patients with Unipolar Depression
by: Rick Dersch, et al.
Published: (2020-07-01)

Antithyroglobulin antibody as a marker of successful ablation therapy in differentiated thyroid cancer
by: Ayu Rosemeilia Dewi, et al.
Published: (2017-01-01)

Potential of the drug-regulation iodide uptake in patients for prevention of radioiodine-refractory papillary thyroid cancer
by: Dmitriy Kirillovich Fomin, et al.
Published: (2014-11-01)

Value of 18F-fluorodeoxyglucose positron emission tomography combined with computed tomography in staging of patients with differentiated thyroid cancer after thyroidectomy during the first course of radioiodine therapy
by: T. M. Geliashvili, et al.
Published: (2021-01-01)

Modulation of Serum Anti-thyroglobulin and Anti-thyroid Microsomal Autoantibody Levels by Levamisole in Patients With Oral Lichen Planus
by: Hung-Pin Lin, et al.
Published: (2011-03-01)

Cannot write session to /tmp/vufind_sessions/sess_37bufjogmjijsbd0konbfcukj1